Valuation Losses Due to Declining Market Prices of Investment Securities
First written in FY2022-Q3. 2 of 5 entries say "Materialised", first in FY2022-Q3. Latest entry: FY2026.
The whole theme swung hardest in 2019: 69 of 144 companies on the "Worse" side.
53 other companies' latest entry also says "Mitigated".
- FY2026MitigatedAnnual report
「For the consolidated fiscal year (from 1 April 2025 to 31 March 2026), there were no applicable matters.」
It was disclosed that no impairment loss on investment securities recognised in the previous fiscal year was recorded in the current consolidated fiscal year. - 2026-05-14Cited as achievedRevision of earnings forecasts
「Net income increased due to the reversal of the impact of the ¥360 million valuation loss on investment securities and the ¥99 million impairment loss on shares of a consolidated subsidiary recorded in the previous fiscal year, as well as the reversal of allowance for doubtful accounts for a consolidated subsidiary.」
The ¥360 million valuation loss on investment securities recorded in the prior fiscal year was cited as one reason for the increase in net income. - FY2023MitigatedAnnual report
「Current consolidated fiscal year (from 1 April 2022 to 31 March 2023): No applicable items.」
It is disclosed that no impairment loss on investment securities was recognised in the current fiscal year for the impairment loss incurred in the previous fiscal year. - FY2022MaterialisedAnnual report
「This represents impairment losses recognised on securities classified as other securities and held by the company's consolidated subsidiaries where the fair value at the end of the period had declined significantly below the acquisition cost.」
An impairment loss on investment securities of ¥37.779 million was recognised as an extraordinary loss, and an actual impairment loss resulting from a decline in the fair value of securities held by a subsidiary was recorded for the full fiscal year. - FY2022-Q3MaterialisedAnnual report
「This represents impairment losses recognised on securities classified as other securities and held by the company's consolidated subsidiaries where the fair value at the end of the period had declined significantly below the acquisition cost.」
An impairment loss on investment securities of ¥33.072 million was recognised as an extraordinary loss for the cumulative third quarter of the current fiscal year, reflecting an actual impairment loss resulting from a decline in the fair value of securities held by a subsidiary.